Development of an enzyme-linked immunosorbent assay for measurement of activity of myristoyl-coenzyme A:protein N-myristoyltransferase

Analytical Biochemistry

Volumn 309, Issue 1, 2002, Pages 137-142

  Takamune, Nobutoki ^a   Hamada, Hirotoshi ^a   Sugawara, Hideki ^a   Misumi, Shogo ^a   Shoji, Shozo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Enzyme linked immunosorbent assay; Myristoylation; N Myristoyltransferase

Indexed keywords

AMINO ACIDS; CATALYSIS; COENZYMES; ENZYME KINETICS; ESCHERICHIA COLI; MONOCLONAL ANTIBODIES;

ABSORBANCE MEASUREMENTS; ENZYME CATALYZED REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH-THROUGHPUT ASSAYS; INHIBITORY ACTIVITY; MYRISTOYLATION; N-MYRISTOYLTRANSFERASE; TETRAMETHYLBENZIDINE;

CHEMICAL DETECTION;

MONOCLONAL ANTIBODY; PROTEIN N MYRISTOYLTRANSFERASE; ACYLTRANSFERASE; BIOTIN; DRUG DERIVATIVE; GLYCINE; GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE; OLIGOPEPTIDE; RECOMBINANT PROTEIN; STREPTAVIDIN;

ARTICLE; CATALYSIS; COVALENT BOND; DERIVATIZATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME KINETICS; ENZYME LINKED IMMUNOSORBENT ASSAY; MEASUREMENT; MYRISTYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; CHEMISTRY; COMPARATIVE STUDY; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; SACCHAROMYCES CEREVISIAE;

ESCHERICHIA COLI;

ACYLTRANSFERASES; AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BIOTIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCINE; HIV-1; OLIGOPEPTIDES; RECOMBINANT PROTEINS; SACCHAROMYCES CEREVISIAE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STREPTAVIDIN;

EID: 0036808337     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-2697(02)00274-9     Document Type: Article

References (21)

1. R.A. Weinberg, C.A. McWherter, S.K. Freeman, D.C. Wood, J.I. Gordon, S.C. Lee, Genetic studies reveal that myristoyl-CoA:protein N-myristoyltransferase is an essential enzyme in Candida albicans, Mol. Microbiol. 16 (1995) 241-250.
2. J.K. Lodge, E. Jackson-Machelski, D.L. Toffaletti, J.R. Perfect, J.I. Gordon, Targeted gene replacement demonstrates that myristoyl-CoA:protein N-myristoyltransferase is essential for viability of Cryptococcus neoformans, Proc. Natl. Acad. Sci. USA 91 (1994) 12008-12012.
3. B. Devadas, S.K. Freeman, M.E. Zupec, H.F. Lu, S.R. Nagarajan, N.S. Kishore, J.K. Lodge, D.W. Kuneman, C.A. McWherter, D.V. Vinjamoori, D.P. Getman, J.I. Gordon, J.A. Sikorski, Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoyl-CoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity, J. Med. Chem. 40 (1997) 2609-2625.
4. S.R. Nagarajan, B. Devadas, M.E. Zupec, SK. Freeman, D.L. Brown, H.F. Lu, P.P. Mehta, N.S. Kishore, C.A. McWherter, D.P. Getman, J.I. Gordon, J.A. Sikorski, Conformationally constrained [p-(ω-aminoalkyl)phenacetyl]-L-seryl-L-lysyl dipeptide amides as potent peptidomimetic inhibitors of Candida albicans and human myristoyl-CoA:protein N-myristoyl transferase, J. Med. Chem. 40 (1997) 1422-1438.
5. J.A. Sikorski, B. Devadas, M.E. Zupec, S.K. Freeman, D.L. Brown, H.F. Lu, S. Nagarajan, P.P. Mehta, A.C. Wade, N.S. Kishore, M.L. Bryant, D.P. Getman, C.A. McWherter, J.I. Gordon, Selective peptidic and peptidomimetic inhibitors of Candida albicans myristoyl-CoA:protein N-myristoyltransferase: A new approach to antifungal therapy, Biopolymers 43 (1997) 43-71.
6. T. Shiraishi, S. Misumi, M. Takama, I. Takahashi, S. Shoji, Myristoylation of human immunodeficiency virus type 1 gag protein is required for efficient env protein transportation to the surface of cells, Biochem. Biophys. Res. Commun. 282 (2001) 1201-1205.
7. K. Furuishi, H. Matsuoka, M. Takama, I. Takahashi, S. Misumi, S. Shoji, Blockage of N-myristoylation of HIV-1 gag induces the production of impotent progeny virus, Biochem. Biophys. Res. Commun. 237 (1997) 504-511.
8. R.V. Rajala, J.M. Radhi, R. Kakkar, R.S. Datla, R.K. Sharma, Increased expression of N-myristoyltransferase in gallbladder carcinomas, Cancer 88 (2000) 1992-1999.
9. R.V. Raju, T.N. Moyana, R.K. Sharma, N-myristoyltransferase overexpression in human colorectal adenocarcinomas, Exp. Cell Res. 235 (1997) 145-154.
10. R.A. McIlhinney, K. Young, M. Egerton, R. Camble, A. White, M. Soloviev, Characterization of human and rat brain myristoyl-CoA:protein N-myristoyltransferase: Evidence for an alternative splice variant of the enzyme, Biochem. J. 333 (1998) 491-495.
11. D.K. Giang, B.F. Cravatt, A second mammalian N-myristoyltransferase, J. Biol. Chem. 273 (1998) 6595-6598.
12. D.A. Towler, S.P. Adams, S.R. Eubanks, D.S. Towery, E. Jackson-Machelski, L. Glaser, J.I. Gordon, Purification and characterization of yeast myristoyl-CoA:protein N-myristoyltransferase, Proc. Natl. Acad. Sci. USA 84 (1987) 2708-2712.
13. M.J. King, R.K. Sharma, N-myristoyltransferase assay using phosphocellulose paper binding, Anal. Biochem. 199 (1991) 149-153.
14. T.A. Farazi, J.K. Manchester, J.I. Gordon, Transient-state kinetic analysis of Saccharomyces cerevisiae myristoyl-CoA:protein N-myristoyltransferase reveals that a step after chemical transformation is rate, Biochemistry 39 (2000) 15807-15816.
15. D.A. Rudnick, C.A. McWherter, S.P. Adams, I.J. Ropson, R.J. Duronio, J.I. Gordon, Structural and functional studies of Saccharomyces cerevisiae myristoyl-CoA:protein N-myristoyltransferase produced in Escherichia coli evidence for an acylenzyme intermediate, J. Biol. Chem. 265 (1990) 13370-13378.
16. C.R. Pennise, N.H. Georgopapadakou, R.D. Collins, N.R. Graciani, D.L. Pompliano, A continuous fluorometric assay of myristoyl-coenzyme A:protein N-myristoyltransferase, Anal. Biochem. 300 (2002) 275-277.
17. R.J. Duronio, E. Jackson-Machelski, R.O. Heuckeroth, P.O. Olins, C.S. Devine, W. Yonemoto, L.W. Slice, S.S. Taylor, J.I. Gordon, Protein N-myristoylation in Escherichia coli: Reconstitution of a eukaryotic protein modification in bacteria, Proc. Natl. Acad. Sci. USA 87 (1990) 1506-1510.
18. gag protein in HIV-1-infected cells, Biochem Biophys. Res. Commun. 222 (1996) 344-351.
19. N. Takamune, T. Tanaka, H. Takeuchi, S. Misumi, S. Shoji, Down-regulation of N-myristoyl transferase expression in human T-cell line CEM by human immunodeficiency virus type-1 infection, FEBS Lett. 506 (2001) 81-84.
20. R.S. Bhatnagar, K. Fütterer, T.A. Farazi, S. Korolev, C.L. Murray, E. Jackson-Machelski, G.W. Gokel, J.I. Gordon, G. Waksman, Structure of N-myristoyltransferase with bound myristoyl-CoA and peptide substrate analogs, Nat. Struct. Biol. 5 (1998) 1091-1097.
21. N. Takamune, S. Misumi, K. Furuishi, S. Shoji, Blockage of HIV-1 production through inhibition of proviral DNA synthesis by N,O-didecanoyl serinal dimethylacetal, IUBMB Life 48 (1999) 311-315.